Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Methimazole
Therapeutic Area : Endocrinology
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Upsher-Smith Launches Methimazole Tablets, USP
Details : Tapazole-Generic (methimazole) is a thyroid peroxidase inhibitor, small molecule drug candidate which is indicated for Graves’ disease with hyperthyroidism or toxic multinodular goiter.
Brand Name : Tapazole-Generic
Molecule Type : Small molecule
Upfront Cash : Not Applicable
March 29, 2024
Lead Product(s) : Methimazole
Therapeutic Area : Endocrinology
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?